Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

A lawsuit filed by the Federal Trade Commission alleges Evoke Wellness LLC and its management services company used deceptive ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Servier, an independent international pharmaceutical group, and Google Cloud have announced an expanded five-year partnership ...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at ...